Publikationen in Zusammenarbeit mit Forschern von Nippon Telegraph and Telephone (Japan) (1)

2021

  1. One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab

    European Journal of Haematology, Vol. 106, Núm. 3, pp. 389-397